InsightfulValue
← Home

Novartis
Novartis

Pharma / Pharmaceuticals and Healthcare


πŸ”§ Tools

βœ… Due Diligence
πŸ“ Financial Growth

Pay attention and research significant changes from year to year values. [ ! ]

Revenue
Growth, %
Net Income
Growth, %
Operating Cash Flow
Growth, %
Free Cash Flow
Growth, %
EPS
Growth, %
EPS Diluted
Growth, %
Operating Income
Growth, %
EBIT
Growth, %
Gross Profit
Growth, %
Ten Y Revenue Growth
Per Share, %
Ten Y Net Income Growth
Per Share, %
Ten Y Operating CF Growth
Per Share, %
Ten Y Shareholders Equity Growth
Per Share, %
Five Y Revenue Growth
Per Share, %
Five Y Net Income Growth
Per Share, %
Five Y Operating CF Growth
Per Share, %
Five Y Shareholders Equity Growth
Per Share, %
Three Y Revenue Growth
Per Share, %
Three Y Net Income Growth
Per Share, %
Three Y Operating CF Growth
Per Share, %
Three Y Shareholders Equity Growth
Per Share, %
Book Value Per Share Growth, %Asset Growth, %Debt Growth, %Dividends per Share
Growth, %
Ten Y Dividend Per Share Growth
Per Share, %
Five Y Dividend Per Share Growth
Per Share, %
Three Y Dividend Per Share Growth
Per Share, %
Weighted Average Shares
Growth, %
Weighted Average Shares Diluted
Growth, %
Receivables Growth, %Inventory Growth, %R&D Expense Growth, %SGA Expenses Growth, %
2024-1210.84 -19.58 21.8617.94 -16.5 -17.32 48.8748.8713.761741.953.82 -24.48 21.7391.4148.15 -9.03 9.7 -44.24 31.12 -26.98 -1.96 2.318.639.1435.8331.4416.05 -3.72 -2.72 17.41 -3.21 -11.86 0.61
2023-12 -9.97 113.511.551.21124.13123.976.216.21 -5.92 -6.77 90.2328.99 -26.21 -2 31.4813.11 -33.71 2.52101.716.13 -9.59 -17.37 -14.9 -5.77 1.5139.7916.2913.84 -4.78 -4.77 -9.08 -17.58 13.75 -12.37
2022-12****************************************************************************************************************************************
2021-12****************************************************************************************************************************************
2020-12****************************************************************************************************************************************
2019-12****************************************************************************************************************************************
2018-12****************************************************************************************************************************************
2017-12****************************************************************************************************************************************
2016-12****************************************************************************************************************************************
Novartis

πŸ“Š Explore more financial growth data for Novartis!

Sign up for free or log in

🎁 Free download! "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal